Graham Alan Jackson

Graham Alan Jackson

Auto-generated profile, based on publicly available information

Graham Alan Jackson

University of the West of Scotland, UK

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 1996 in BMJ
Verified
Journal Article
Closed access
AMAlice M McGrath
Alice M McGrath
GJGraham A Jackson
Graham A Jackson
In the United States concern about the often excessive use of neuroleptics in residents of nursing homes in the 1980s1 led to new legislation, which included guidelines on the use of these agents in nursing homes and also (uniquely) placed restrictions on physicians' prescribing of neuroleptics within nursing homes. We measured the prevalence of neuroleptic prescribing in nursing homes in south Glasgow and assessed what effects the American legislation might have if it were applied here. We visited 28 nursing homes in the south of Glasgow and examined the medicine dispensing sheets of all 909 residents. We identified those taking neuroleptics regularly and collected information on the drugs and dosages prescribed. We interviewed a senior member of nursing staff in each home to collect information on age, …

2 May 2018 in Dementia
Verified
Journal Article
Open access
WAWilson Abreu
Wilson Abreu
DTDebbie Tolson
Debbie Tolson
GJGraham A Jackson
Graham A Jackson
NCNilza Costa
Nilza Costa
Psychological health of caregivers of people with dementia is a major public concern. This study sought to determine the relationship between caregiver burden, psychological distress, frailty and functional dependency of a relative with advanced dementia. Persons with dementia and their caregivers (102 dyads) participated in this Portuguese community based cross-sectional study. Data were collected using the Clinical Dementia Rating Scale, a sociodemographic questionnaire, the Zarit Burden Interview, the Brief Symptoms Inventory and the Edmonton Frail Scale. Alzheimer's disease was the most common type of dementia among the recipients of care, who showed moderate (42.2%) to severe (52.9%) dementia. Among them 35.3% exhibited moderate and 45.1% severe frailty. Family caregivers reported moderate (76.5%) to severe burden (18.6%). Psychological distress was very high among family caregivers. Results show that people with dementia exhibited moderate (35.3%) or severe frailty (45.1%) and that a severe frailty was found in people with moderate dementia. A one-way ANOVA was conducted between the Global Severity Index and some sociodemographic variables. ANOVA reached p < .01 for employment status of the caregiver, assistance and professional support, and psychiatric history; and p = 0.01 for caregiver age and years of caregiving. Although caregivers reported benefit from the supportive approach offered by the multidisciplinary home care team, high levels of distress and associated burden were found, which might decrease their capacity to care for the person with dementia and their own health and well-being.

14 November 2011 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
PDF file
SLStephen Lithgow
Stephen Lithgow
GJGraham A. Jackson
Graham A. Jackson
DBDebbie Browne
Debbie Browne

31 August 2006 in BMJ
Verified
Journal Article
Closed access
PDF file
APAnthony J Pelosi
Anthony J Pelosi
SMSeamus V McNulty
Seamus V McNulty
GJGraham A Jackson
Graham A Jackson
Unanswered questions NICE and its main advisers acknowledged shortcomings in their and others' economic analyses. Calculation of quality adjusted life years (QALYs) has been based on cross sectional data from carers of patients with Alzheimer's disease using the health utility index, which was not designed for use in dementia.4 A major influence on costs is the duration from onset until full time nursing care is required. However, this is crucially influenced by characteristics of the care givers, as well as patients' cognitive functioning, neuropsychiatric symptoms, and functional abilities and social, cultural, financial, and health service issues.5 6 The randomised trials did not directly examine whether cholinesterase inhibitors delayed placement in care homes, but this was assumed on the basis of evidence of a slow down in cognitive decline.2 NICE stressed that further research was required—not just drug trials but also examination of other key interventions such as home support and rehabilitation. It flagged up the need for improved measures of outcome that were meaningful to patients, carers, and policy makers, and it planned to revisit its recommendations after several years.1 2

1 March 2003 in The British Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
SMSeamus V. Mcnulty
Seamus V. Mcnulty
LDLaing Duncan
Laing Duncan
MSMargaret Semple
Margaret Semple
GJGraham A. Jackson
Graham A. Jackson
APAnthony J. Pelosi
Anthony J. Pelosi
Background Little is known of the needs of elderly patients with psychotic illnesses.

26 July 2016 in Dementia
Verified
Journal Article
Closed access
EHElizabeth Hanson
Elizabeth Hanson
AHAmanda Hellstrom
Amanda Hellstrom
ÅSÅsa Sandvide
Åsa Sandvide
GJGraham A Jackson
Graham A Jackson
RMRhoda Macrae
Rhoda Macrae
DTDebbie Tolson
Debbie Tolson
This article presents an integrative literature review of the experience of dementia care associated with the extended palliative phase of dementia. The aim was to highlight how dementia is defined in the literature and describe what is known about the symptomatology and management of advanced dementia regarding the needs and preferences of the person with dementia and their family carer/s. There was no consistent definition of advanced dementia. The extended palliative phase was generally synonymous with end-of-life care. Advanced care planning is purported to enable professionals to work together with people with dementia and their families. A lack of understanding of palliative care among frontline practitioners was related to a dearth of educational opportunities in advanced dementia care. There are few robust concepts and theories that embrace living the best life possible during the later stages of dementia. These findings informed our subsequent work around the concept, ‘Dementia Palliare’.